Overcoming multidrug-resistant lung cancer by mitochondrial-associated ATP inhibition using nanodrugs

Despite the development of therapeutic modalities to treat cancer, multidrug resistance (MDR) and incomplete destruction of deeply embedded lung tumors remain long-standing problems responsible for tumor recurrence and low survival rates. Therefore, developing therapeutic approaches to treat MDR tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jun-Young, Lee, Gyu-Ho, Yoo, Kwai Han, Khang, Dongwoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835376/
https://www.ncbi.nlm.nih.gov/pubmed/36635755
http://dx.doi.org/10.1186/s12951-023-01768-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835376/
https://www.ncbi.nlm.nih.gov/pubmed/36635755
http://dx.doi.org/10.1186/s12951-023-01768-8

Ejemplares similares